Heartflow alleges that after working as its consultant, Cleerly’s CEO launched a competing enterprise “built upon” Heartflow’s innovations.
The complete study cohort includes 1,023 patients from 22 sites in Europe.
Amplitude Vascular’s lead development product is an intravascular lithotripsy platform for calcified peripheral artery disease treatment.
Used with Beckman’s immunoassay analysers, MeMed’s BV test has been demonstrated to reduce unnecessary antibiotic use.
The test operates on the company's cobas instruments, providing standardised results regardless of location.
Aiva’s AI assistant enables nurses to use natural voice commands for documentation and work order submissions.
